Imagine picking up the Wall Street Journal one morning and seeing a write-up about FDA violations that occurred on your conference's show floor. It's not a far-fetched scenario — it happened to the American Society of Clinical Oncology, the American Urological Association, and the American Society of Health-System Pharmacists this summer after a crackdown on exhibitors by the FDA's Division of Drug Marketing, Advertising, and Communications. DDMAC enforces FDA rules regarding
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments